Cover Image

Optimizing response to gefitinib in the treatment of non-small-cell lung cancer

Pietro Carotenuto1, Cristin Roma1, Anna Maria Rachiglio1, Raffaella Pasquale1, Renato Franco2, Giuseppe Antinolfi3, Francovito Piantedosi4, Alfonso Illiano5, Gerardo Botti2, Alessandro Morabito6, Nicola Normanno7, Antonella De Luca71Pharmacogenomic Laboratory, CROM – Centro Ricerche Oncolo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pietro Carotenuto (Author), Cristin Roma (Author), Anna Maria Rachiglio (Author), et al (Author)
Format:	Book
Published:	Dove Medical Press, 2011-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC)
by: M Tiseo, et al.
Published: (2010)

Modeling Tumor Growth and Treatment Resistance Dynamics Characterizes Different Response to Gefitinib or Chemotherapy in Non‐Small Cell Lung Cancer
by: Mario Nagase, et al.
Published: (2020)

Anticancer Effects of Amlodipine Alone or in Combination With Gefitinib in Non-Small Cell Lung Cancer
by: Bingjie Fu, et al.
Published: (2022)

Polyphyllin VII increases sensitivity to gefitinib by modulating the elevation of P21 in acquired gefitinib resistant non-small cell lung cancer
by: Honggang Wang, et al.
Published: (2017)

Skin manifestations of gefitinib and the association with survival of advanced non-small-cell lung cancer in Taiwan
by: Shiou-Han Wang, et al.
Published: (2011)

Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma
by: Farah Al-Sahlawi, et al.
Published: (2024)

Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR Transactivation
by: Yuhong Jiang, et al.
Published: (2021)

The combination of MnO2@Lipo-coated gefitinib and bevacizumab inhibits the development of non-small cell lung cancer
by: Jisong Zhang, et al.
Published: (2022)

Cost-Effectiveness Analysis of Gefitinib Alone and Combined with Chemotherapy as First-Line Treatment for Patients with Advanced Non-Small-Cell Lung Cancer
by: Wang Y, et al.
Published: (2022)

Combination Therapy of Gefitinib and Korean Herbal Medicines Could be a Beneficial Option for Patients with Non-Small-Cell Lung Cancer
by: Kangwook Lee, et al.
Published: (2016)

PHARMACOECONOMIC EVALUATION OF THE MEDICINAL PRODUCTS ERLOTINIB, DOCETAXEL, PEMETREXED AND GEFITINIB IN THE SECOND-LINE TREATMENT OF LOCALLY-ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER
by: A. U. Kulikov
Published: (2015)

Effects of cilengitide derivatives on TGF-β1-induced epithelial-to-mesenchymal transition and invasion in gefitinib-resistant non-small cell lung cancer cells
by: Yujin Seo, et al.
Published: (2023)

Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway
by: Jiali Wang, et al.
Published: (2024)

circSETD3 Contributes to Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer by Targeting the miR-520h/ABCG2 Pathway
by: Yutang Huang, et al.
Published: (2020)

Cyclic RGD Pentapeptide Cilengitide Enhances Efficacy of Gefitinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Invasion in Human Non-Small Cell Lung Cancer Cells
by: Jisu Jeong, et al.
Published: (2021)

Gefitinib-loaded starch nanoparticles for battling lung cancer: Optimization by full factorial design and in vitro cytotoxicity evaluation
by: Haitham Amin, et al.
Published: (2023)

Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment
by: Vineela Parvathaneni, et al.
Published: (2020)

Yang-Yin-Jie-Du decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway
by: Shu-yi Chen, et al.
Published: (2021)

Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non‐Small Cell Lung Cancer
by: Benjamin K. Schneider, et al.
Published: (2019)

In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer
by: Xiao Ling Ni, et al.
Published: (2017)

Sintilimab for the treatment of non-small cell lung cancer
by: Lin Zhang, et al.
Published: (2022)

Silencing of Long Non-coding RNA MIAT Sensitizes Lung Cancer Cells to Gefitinib by Epigenetically Regulating miR-34a
by: Yunfeng Fu, et al.
Published: (2018)

Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
by: Arwa Omar Al Khatib, et al.
Published: (2023)

Retraction Notice to: lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer
by: Xiliu Chen, et al.
Published: (2024)

The Underlying Mechanism Involved in Gefitinib Resistance and Corresponding Experiment Validation in Lung Cancer
by: Puwei Song, et al.
Published: (2023)

Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
by: Thomas Rodier, et al.
Published: (2022)

Progressive Disease with Mixed Response After Immunotherapy in Non-Small Cell Lung Cancer
by: Lv J, et al.
Published: (2024)

Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 Dimers
by: Hawon Yoo, et al.
Published: (2021)

EGFR mutation testing in non-small cell lung cancer (NSCLC)
by: Fouad Al Dayel
Published: (2012)

Efficacy of gefitinib and radiotherapy combination in Indonesian patients with lung adenocarcinoma
by: Syahruddin Elisna, et al.
Published: (2018)

Chemoresistance factors in non-small cell lung cancer
by: А. I. Shevchenko, et al.
Published: (2016)

Initial Systemic Treatment of Advanced Non-small Cell Lung Cancer
by: Muhammad Kamran Siddique, et al.
Published: (2019)

Non-Small-Cell Lung Cancer. Unusual Small Bowel Metastasis with Invagination
by: Miguel Ángel Serra Valdés, et al.
Published: (2017)

Non-Small-Cell Lung Cancer. Unusual Small Bowel Metastasis with Invagination
by: Miguel Ángel Serra Valdés, et al.
Published: (2017)

Current status of immunotherapy for non-small cell lung cancer
by: Tao Yang, et al.
Published: (2022)

PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY
by: A. V. Rudakova, et al.
Published: (2017)

Iterative surgical resections in non-small cell lung cancer
by: Ahmet Ucvet, et al.
Published: (2022)

Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer
by: Zaid Sirhan, et al.
Published: (2023)

First line Immunotherapy for Non-Small Cell Lung Cancer
by: Nicola J. Nasser, et al.
Published: (2020)

The inhibitory effect of dihydroartemisinin on non-small cells lung cancer
by: Yan Li, et al.
Published: (2021)